Krystal Biotech (KRYS)
339.06
-0.16 (0.05%)
Upcoming Events
Latest Headlines
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
July 20, 2026 5:43 PM - PR NewsWire
Krystal Biotech to join S&P MidCap 400, Tutor Perini and V2X to join S&P SmallCap 600
July 20, 2026 5:16 PM - StreetInsider
Krystal Biotech (KRYS) PT Raised to $396 at BofA Securities
July 13, 2026 11:05 AM - StreetInsider
TD Cowen highlights this stock as a best SMID-cap idea with multiple 2026 catalysts
July 2, 2026 12:00 AM - StreetInsider
Form 4 Krystal Biotech, Inc. For: Jun 25 Filed by: Thomas John Charles
June 26, 2026 6:46 PM - SEC Filing
Krystal Biotech (KRYS) PT Raised to $395 at Evercore ISI
June 26, 2026 8:26 AM - StreetInsider
Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles
June 25, 2026 10:04 AM - SEC Filing
Krystal Biotech (KRYS) PT Raised to $403 at TD Cowen
June 18, 2026 7:48 AM - StreetInsider
Krystal Biotech (KRYS) PT Raised to $361 at H.C. Wainwright
June 17, 2026 6:48 AM - StreetInsider
Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Suma
June 5, 2026 6:41 PM - SEC Filing
Form 4 Krystal Biotech, Inc. For: Jun 04 Filed by: Krishnan Krish S
June 5, 2026 6:39 PM - SEC Filing
Form 144 Krystal Biotech, Inc. Filed by: Krishnan Suma
June 4, 2026 4:31 PM - SEC Filing
Form 144 Krystal Biotech, Inc. Filed by: Krishnan Krish S
June 4, 2026 4:31 PM - SEC Filing
Form 4 Krystal Biotech, Inc. For: May 26 Filed by: Thomas John Charles
May 27, 2026 5:18 PM - SEC Filing
Form 144 Krystal Biotech, Inc. Filed by: Thomas John Charles
May 26, 2026 10:31 AM - SEC Filing
Corbus names Nishant Saxena as chief business officer
May 21, 2026 8:01 AM - StreetInsider
Form 8-K Krystal Biotech, Inc. For: May 15
May 20, 2026 6:02 AM - SEC Filing
Krystal Biotech gains UK approval for VYJUVEK gene therapy
May 18, 2026 8:02 AM - StreetInsider
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 18, 2026 8:01 AM - Globe NewsWire
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
May 7, 2026 8:00 AM - Globe NewsWire
Krystal Biotech (KRYS) PT Raised to $399 at Jefferies
May 4, 2026 2:04 PM - StreetInsider
Krystal Biotech (KRYS) PT Lowered to $323 at BofA Securities
May 4, 2026 10:40 AM - StreetInsider
Form SCHEDULE 13G/A Krystal Biotech, Inc. Filed by: Krishnan Krish S
May 4, 2026 7:11 AM - SEC Filing
Form 8-K Krystal Biotech, Inc. For: May 04
May 4, 2026 7:07 AM - SEC Filing
Form 10-Q Krystal Biotech, Inc. For: Mar 31
May 4, 2026 7:06 AM - SEC Filing
Krystal Biotech, Inc. (KRYS) Tops Q1 EPS by 35c
May 4, 2026 7:03 AM - StreetInsider
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
May 4, 2026 7:00 AM - Globe NewsWire
Krystal Biotech to Present at Upcoming Scientific Conferences
April 30, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G Krystal Biotech, Inc. Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
April 29, 2026 2:16 PM - SEC Filing
Full Article List
